#	Pagina
attuale pagina	/open-h2020/projects/199372/index.html
-1	/open-h2020/projects/205193/index.html
-2	/open-h2020/projects/217863/index.html
-3	/open-h2020/projects/211059/index.html
-4	/open-h2020/projects/226822/index.html
-5	/open-h2020/projects/205935/index.html
-6	/open-h2020/projects/194419/index.html
-7	/open-h2020/projects/197264/index.html
-8	/open-h2020/projects/204253/index.html
-9	/open-h2020/projects/221031/index.html
-10	/open-h2020/projects/196130/index.html

Opendata, web and dolomites

F-CCW

Functional Cell Culture Ware (F-CCW) : Technical and Commercial feasible?

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

F-CCW project word cloud

Explore the words cloud of the F-CCW project. It provides you a very rough idea of what is the project "F-CCW" about.

materials pharmaceutical invented cells pharmaceuticals breakthrough contact culture economic expensive substantially efficient manufacturing innovative surface cell creates stay topographies marginally return ccw alive investors ware human requiring follow producing create toxicology venture speed organ functionalized screening moulds periods upcoming transfer drug topography transferring feasibility market industry manufacturers commercial specialists compounds plan dramatically investment select volume multiple coating grow conventional toxicological industries performance goals asian markets model limited inlay medicine laboratories facility global chemical throughput explore innovatively personalized designed medical therapies materiomics stakeholders network business therapeutics topochip moulding demand injection highest generation

Project "F-CCW" data sheet

The following table provides information about the project.

Coordinator	MATERIOMICS BV Organization address address: OXFORDLAAN 70 city: MAASTRICHT postcode: 6229 EV website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Netherlands [NL]
Project website	http://www.materiomcs.com
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument) 2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
Code Call	H2020-SMEINST-1-2015
Funding Scheme	SME-1
Starting year	2015
Duration (year-month-day)	from 2015-12-01 to 2016-05-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	MATERIOMICS BV MATERIOMICS BV Organization address address: OXFORDLAAN 70 city: MAASTRICHT postcode: 6229 EV website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NL (MAASTRICHT)	coordinator	50˙000.00

Map

Project objective

The market for testing of pharmaceuticals and the demand for human cells for cell therapies will grow substantially. Conventional cell culture and organ- model systems (C-CCW) are complex and expensive, due to chemical coating compounds requiring multiple production steps, and marginally effective as cells stay alive for short periods and/or grow at low speed. The performance of cell culture systems and organ model systems can be dramatically improved by using materials with designed surface topography.

Materiomics has invented an innovative TopoChip high-throughput screening technology. The overall aim is to innovatively set up enabling technology to transfer the designed topographies to C-CCW products in a high-volume, low-cost manufacturing process (leading to phase 2 application). It creates the next generation products: Functionalized Cell Culture Ware ( F-CCW )which is simple, highly effective and efficient.

Goals in Phase 1 are to: 1. Demonstrate the technical feasibility of transferring designed topographies on C-CCW 2. Explore commercial feasibility of F-CCW: to develop a business plan. 3. Develop production methods for producing F-CCW 4. Select cell culture system applications that allow for the highest expected economic return on investment. 5. Identify (and contact) network partnerships for creating a production facility for F-CCW’s

Potential end users are research driven industries of drug development, toxicology, personalized medicine and cell therapeutics. Potential stakeholders are investors, injection moulding specialists, manufacturers of moulds for inlay, testing and research laboratories for medical and toxicological testing and pharmaceutical industry. The market is a global market (EU, US and upcoming Asian markets).

F-CCW is a breakthrough in functionality of cell culture. Since F-CCW is not limited to one application only, F-CCW will offer multiple follow-up investment opportunities and create many opportunities for new venture

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "F-CCW" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "F-CCW" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.2.1.2.)

S3D (2015)

Feasibility study to determine the use of ITS technology to replace nuclear density meters in mining, dredging and other areas of hydraulic transport.